(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HAEMOBALANS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

HAEMOBALANS

ST13

US500000079226648

Class

5

Filing

79226648

Registration

5677223

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

05/06/2026

Trademark type

Word

Nice classes

5

Filing date

11/23/2017

Registration date

02/19/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/05/2025

Last transaction

05/06/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

98

Owner location

RU

Examiner

LEASER, ANDREW C

Law office

M80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

P. V. (pessoa física)
Obshchestvo s ogranichennoy otvetstvennostyu "Rosvetsnab"

Representatives

Seleznev Gleb

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Dietary supplements for animals; amino acids for veterinary purposes; vitamin preparations

Publications

History of USPTO decisions and trademark events.

27 publications found

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

05/05/2026

C71T

CANCELLED SECTION 71

09/05/2025

CHLD

CHANGE OF OWNER RECEIVED FROM IB

02/19/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/16/2019

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

06/07/2019

XXCR

GENERIC MADRID TRANSACTION CREATED

06/07/2019

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/19/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

02/19/2019

PUBO

PUBLISHED FOR OPPOSITION

12/04/2018

GPNX

NOTIFICATION PROCESSED BY IB

11/30/2018

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/14/2018

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/14/2018

NPUB

NOTICE OF PUBLICATION

11/14/2018

ALIE

ASSIGNED TO LIE

10/27/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/15/2018

CNEA

EXAMINERS AMENDMENT MAILED

10/15/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

10/15/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/15/2018

RFNP

REFUSAL PROCESSED BY IB

04/06/2018

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/19/2018

RFRR

REFUSAL PROCESSED BY MPU

03/19/2018

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/13/2018

CNRT

NON-FINAL ACTION WRITTEN

03/12/2018

DOCK

ASSIGNED TO EXAMINER

03/08/2018

MAFR

APPLICATION FILING RECEIPT MAILED

02/27/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/23/2018

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/15/2018

Continuous trademark protection

Get notified about every new filing that threatens HAEMOBALANS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.